Summary of findings for pregnancy subgroup: utility, RIO, or health state value information
| Health state/outcome (categories of values and preferences) . | Estimates of utilities . | Certainty in evidence . | Interpretation of findings . |
|---|---|---|---|
| No. of participants/studies . | |||
| Pregnancy-related DVT (Bates et al24 ) | VAS: 46 (IQR, 30-65) | ⊕⊕○○ Low certainty due to inconsistency and imprecision*,† | Women might possibly find pregnancy-related DVT having an important impact on their lives. There is likely an important variability for this assessment. |
| 123 participants from 1 study based on VAS | |||
| Pregnancy-related PE (Bates et al24 ) | VAS: 30 (IQR, 15-50) | ⊕⊕○○ Low certainty due to inconsistency and imprecision*,† | Most women might possibly find pregnancy-related PE having an important impact on their lives. There is likely an important variability for this assessment. |
| 123 participants from 1 study based on VAS | |||
| Obstetric bleeding (Bates et al24 ) | VAS: 30 (IQR, 15-50) | ⊕⊕○○ Low certainty due to inconsistency and imprecision*,† | Most women might possibly find obstetric bleeding having an important impact on their lives. There is likely an important variability. |
| 123 participants from 1 study based on VAS | |||
| Treatment with LMWH (Bates et al24 ) | Visual analog scale: 83 (IQR, 70-90) | ⊕⊕⊕○ Moderate certainty due to imprecision† | Women may probably find treatment with LMWH having a small impact on their lives. There is some variability for this assessment. |
| 123 participants from 1 study based on VAS |
| Health state/outcome (categories of values and preferences) . | Estimates of utilities . | Certainty in evidence . | Interpretation of findings . |
|---|---|---|---|
| No. of participants/studies . | |||
| Pregnancy-related DVT (Bates et al24 ) | VAS: 46 (IQR, 30-65) | ⊕⊕○○ Low certainty due to inconsistency and imprecision*,† | Women might possibly find pregnancy-related DVT having an important impact on their lives. There is likely an important variability for this assessment. |
| 123 participants from 1 study based on VAS | |||
| Pregnancy-related PE (Bates et al24 ) | VAS: 30 (IQR, 15-50) | ⊕⊕○○ Low certainty due to inconsistency and imprecision*,† | Most women might possibly find pregnancy-related PE having an important impact on their lives. There is likely an important variability for this assessment. |
| 123 participants from 1 study based on VAS | |||
| Obstetric bleeding (Bates et al24 ) | VAS: 30 (IQR, 15-50) | ⊕⊕○○ Low certainty due to inconsistency and imprecision*,† | Most women might possibly find obstetric bleeding having an important impact on their lives. There is likely an important variability. |
| 123 participants from 1 study based on VAS | |||
| Treatment with LMWH (Bates et al24 ) | Visual analog scale: 83 (IQR, 70-90) | ⊕⊕⊕○ Moderate certainty due to imprecision† | Women may probably find treatment with LMWH having a small impact on their lives. There is some variability for this assessment. |
| 123 participants from 1 study based on VAS |
Moderate certainty in evidence: We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low certainty in evidence: Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
IQR, interquartile range; VAS, visual analog scale.
Inconsistency due to important variability.
Imprecision due to small sample size.